Efficacy and safety of ivonescimab in non-small cell lung cancer: a systematic review and meta-analysis of emerging clinical data.

Front Pharmacol · 2026 · PMC12909539 · PMID 41710928

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Subgroup analysis by treatment demonstrated that AK112 combined with chemotherapy was associated with an increased risk of all-grade AEs (OR = 2.70, 95% CI: 0.71–10.26; Figure 5C ), though this result did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.